Induced pluripotent stem cells: the new patient?
- PMID: 23034453
- DOI: 10.1038/nrm3448
Induced pluripotent stem cells: the new patient?
Abstract
Worldwide increases in life expectancy have been paralleled by a greater prevalence of chronic and age-associated disorders, particularly of the cardiovascular, neural and metabolic systems. This has not been met by commensurate development of new drugs and therapies, which is in part owing to the difficulty in modelling human diseases in laboratory assays or experimental animals. Patient-specific induced pluripotent stem (iPS) cells are an emerging paradigm that may address this. Reprogrammed somatic cells from patients are already applied in disease modelling, drug testing and drug discovery, thus enabling researchers to undertake studies for treating diseases 'in a dish', which was previously inconceivable.
Similar articles
-
Recent advances in iPSC technologies involving cardiovascular and neurodegenerative disease modeling.Gen Physiol Biophys. 2016 Jan;35(1):1-12. doi: 10.4149/gpb_2015023. Epub 2015 Oct 22. Gen Physiol Biophys. 2016. PMID: 26492069 Review.
-
Bioengineered stem cells in neural development and neurodegeneration research.Ageing Res Rev. 2013 Jun;12(3):739-48. doi: 10.1016/j.arr.2013.04.002. Epub 2013 May 4. Ageing Res Rev. 2013. PMID: 23651546 Free PMC article. Review.
-
Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.Expert Opin Drug Discov. 2015 Jun;10(6):615-29. doi: 10.1517/17460441.2015.1037737. Epub 2015 Apr 20. Expert Opin Drug Discov. 2015. PMID: 25891144 Review.
-
Human-induced pluripotent stem cells: in quest of clinical applications.Mol Biotechnol. 2012 Oct;52(2):193-203. doi: 10.1007/s12033-012-9504-0. Mol Biotechnol. 2012. PMID: 22302314 Review.
-
Induced pluripotent stem cells for regenerative cardiovascular therapies and biomedical discovery.Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):324-30. doi: 10.1016/j.addr.2011.01.013. Epub 2011 Mar 1. Adv Drug Deliv Rev. 2011. PMID: 21371511 Free PMC article. Review.
Cited by
-
Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis.Stem Cells Transl Med. 2013 Mar;2(3):167-74. doi: 10.5966/sctm.2012-0042. Epub 2013 Feb 14. Stem Cells Transl Med. 2013. PMID: 23413376 Free PMC article.
-
Gene correction and overexpression of TNNI3 improve impaired relaxation in engineered heart tissue model of pediatric restrictive cardiomyopathy.Dev Growth Differ. 2024 Feb;66(2):119-132. doi: 10.1111/dgd.12909. Epub 2024 Jan 9. Dev Growth Differ. 2024. PMID: 38193576 Free PMC article.
-
Disease-specific phenotypes in iPSC-derived neural stem cells with POLG mutations.EMBO Mol Med. 2020 Oct 7;12(10):e12146. doi: 10.15252/emmm.202012146. Epub 2020 Aug 25. EMBO Mol Med. 2020. PMID: 32840960 Free PMC article.
-
Autism spectrum disorders: emerging mechanisms and mechanism-based treatment.Front Cell Neurosci. 2015 May 12;9:183. doi: 10.3389/fncel.2015.00183. eCollection 2015. Front Cell Neurosci. 2015. PMID: 26029053 Free PMC article. No abstract available.
-
Diabetes-associated macrovascular complications: cell-based therapy a new tool?Endocrine. 2013 Dec;44(3):557-75. doi: 10.1007/s12020-013-9936-8. Epub 2013 Mar 30. Endocrine. 2013. PMID: 23543434 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous